Scolaris Content Display Scolaris Content Display

مقایسه زایمان زودهنگام برنامه‌ریزی شده در برابر مدیریت انتظاری برای نوزاد ترم و مشکوک به در معرض خطر برای بهبود پیامدها

Contraer todo Desplegar todo

Referencias

منابع مطالعات واردشده در این مرور

Boers 2010 {published data only}

Bijlenga D, Boers KE, Birnie E, Mol BW, Vijgen SC, Van der Post JA, et al. Maternal health‐related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks. Quality of Life Research 2011;20(9):1427‐36. CENTRAL
Boers K, Vijgen S, Bijlenga D, Van Der Post J, Bekedam D, Kwee A, et al. Induction of labour versus expectant monitoring for intrauterine growth restriction at term (The Digitat Trial): a multicentre randomised controlled trial. American Journal of Obstetrics and Gynecology 2009;201(6 Suppl 1):S3. CENTRAL
Boers KE, Bijlenga D, Mol BW, LeCessie S, Birnie E, van Pampus MG, et al. Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy & Childbirth 2007;7:12. CENTRAL
Boers KE, Vijgen SMC, Bijlenga D, Van Der Post JAM, Bekedam DJ, Kwee A, et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 2010;341:c7087. CENTRAL
Boers KE, van Wyk L, van der Post JA, Kwee A, van Pampus MG, Spaanderdam ME, et al. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT. American Journal of Obstetrics & Gynecology 2012;206(4):344.e1‐7. CENTRAL
Chauhan S, Tajik P, Boers K, van Wyk L, Mol B, Scherjon S. Differentiating newborns with birth weight < vs > 3 percentiles for gestational age: secondary‐analysis of a randomized clinical trial (DIGITAT). American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S177‐S178. CENTRAL
Tajik P, Boers K, van Wyk L, Mol B, Sicco S. Evaluation of markers guiding management decision for intrauterine growth restriction: a sub‐analysis of a randomized trial, DIGITAT. American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S199‐S200. CENTRAL
Tajik P, van Wyk L, Boers KE, le Cessie S, Zafarmand MH, Roumen F, et al. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2014;172:20‐5. CENTRAL
Van Wyk L. Effects on (neuro) developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intra‐uterine growth restricted infants: long‐term outcomes of the DIGITAT‐trial. American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S19‐S20. CENTRAL
Van Wyk L, Boers KE, Van der Post JAM, Van Pampus MG, Van Wassenaer AG, Van Baar AL, et al. DIGITAT Study Group. Effects on (neuro) developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth‐restricted infants: Long‐term outcomes of the DIGITAT trial. American Journal of Obstetrics and Gynecology 2012;206(5):406.e1‐406.e7. CENTRAL
Vijgen SM, Boers KE, Opmeer BC, Bijlenga D, Bekedam DJ, Bloemenkamp KW, et al. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial). European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013;170(2):358‐63. CENTRAL
Willekes C, van der Post J, Mol BW, Roumen F, Boers K, Delemarre F, et al. Neonatal morbidity after induction vs expectant monitoring in at term growth restriction (DIGITAT trial). American Journal of Obstetrics and Gynecology 2011;204(1 Suppl 1):S71. CENTRAL

Ek 2005 {published data only}

Ek S, Andersson A, Johansson A, Kublicas M. Oligohydramnios in uncomplicated pregnancies beyond 40 completed weeks A prospective, randomised, pilot study on maternal and neonatal outcomes. Fetal Diagnosis and Therapy 2005;20(3):182‐5. CENTRAL

van den Hove 2006 {published data only}

van den Hove MM, Willekes C, Roumen FJ, Scherjon SA. Intrauterine growth restriction at term: induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): a pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2006;125(1):54‐8. CENTRAL

منابع مطالعات خارج‌شده از این مرور

Conway 2000 {published data only}

Conway DL, Groth S, Adkins WB, Langer O. Management of isolated oligohydramnios in the term pregnancy: a randomized clinical trial. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S21. CENTRAL

Dogra 2012 {published data only}

Dogra Y. Elective induction vs spontaneous labour in patients with heart disease. ClinicalTrials.gov2012. CENTRAL

Nicholson 2008 {published data only}

Nicholson J, Caughey A, Parry S, Rosen S, Evans A, Macones G. Prospective randomized trial of the active management of risk in pregnancy at term: improved birth outcomes from prostaglandin‐assisted preventive labor induction. American Journal of Obstetrics and Gynecology 2007;197(6 Suppl 1):S37, Abstract no: 84. CENTRAL
Nicholson JM, Parry S, Caughey AB, Rosen S, Keen A, Macones GA. The impact of the active management of risk in pregnancy at term on birth outcomes: a randomized clinical trial. American Journal of Obstetrics & Gynecology 2008;198(5):511.e1‐511.e15. CENTRAL
Peek MJ, Nanan RK. The role of sepsis in the AMOR‐IPAT Trial... (Am J Obstet Gynecol. 2008 May;198(5):511.e1‐15). American Journal of Obstetrics & Gynecology 2009;200(4):e12. CENTRAL

Pri‐Paz 2008 {published data only}

Pri‐Paz SM. Active management of risk in pregnancy at term to reduce rate of cesarean deliveries (AMOR IPAT). ClinicalTrials.gov (http://clinicaltrials.gov) accessed 19 February 2008. CENTRAL

Alfirevic 2013

Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high‐risk pregnancies. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD007529.pub3]

ANZSA 2010

Preston S, Mahomed K, Chadha Y, Flenady V, Gardener G, MacPhail J, et al. Clinical Practice Guideline for the Management of Women Who Report Decreased Fetal Movements. Australia and New Zealand Stillbirth Alliance (ANZSA), July 2010.

Bijlenga 2011

Bijlenga D, Boers KE, Birnie E, Mol BW, Vijgen SC, Van der Post JA, et al. Maternal health‐related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks. Quality of Life Research 2011;20(9):1427‐36.

Boers 2007

Boers KE, Bijlenga D, Mol BW, LeCessie S, Birnie E, van Pampus MG, et al. Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy & Childbirth 2007;7:12.

Boers 2009

Boers K, Vijgen S, Bijlenga D, Van Der Post J, Bekedam D, Kwee A, et al. Induction of labour versus expectant monitoring for intrauterine growth restriction at term (The Digitat Trial): a multicentre randomised controlled trial. American Journal of Obstetrics and Gynecology 2009;201(6 Suppl 1):S3.

Boers 2012

Boers KE, van Wyk L, van der Post JA, Kwee A, van Pampus MG, Spaanderdam ME, et al. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT. American Journal of Obstetrics & Gynecology 2012;206(4):344.e1‐7.

Boulvain 2001

Boulvain M, Stan CM, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD001997]

Brown 1981

Brown R, Patrick J. The nonstress test: how long is enough?. American Journal of Obstetrics & Gynecology 1981;141(6):646‐51.

Chauhan 2012

Chauhan S, Tajik P, Boers K, van Wyk L, Mol B, Scherjon S. Differentiating newborns with birth weight < vs > 3 percentiles for gestational age: secondary‐analysis of a randomized clinical trial (DIGITAT). American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S177‐S178.

Cheng 2008

Cheng YW, Nicholson JM, Nakagawa S, Bruckner TA, Washington AE, Caughey AB. Perinatal outcomes in low‐risk term pregnancies: do they differ by week of gestation?. American Journal of Obstetrics and Gynecology 2008;199:370.e1‐370.e7.

Evertson 1979

Evertson LR,  Gauthier RJ,  Schifrin BS,  Paul RH. Antepartum fetal heart rate testing. I. Evolution of the nonstress test. American Journal of Obstetrics and Gynecology 1979;133(1):29‐33.

Froen 2004

Froen JF. A kick from within ‐ fetal movement counting and the cancelled progress in antenatal care. Journal of Perinatal Medicine 2004;32:13‐24.

Froen 2008

Froen JF, Tveit JV, Saastad E, Bordahl PE, Stray‐Pedersen B, Heazell AE, et al. Management of decreased fetal movements. Seminars in Perinatology 2008;32(4):307‐11.

Grivell 2015

Grivell RM, Alfirevic Z, Gyte GML, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD007863.pub4]

Gülmezoglu 2012

Gülmezoglu AM, Crowther CA, Middleton P, Heatley E. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD004945]

Higgins 2011

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hofmeyr 2012

Hofmeyr GJ, Novikova N. Management of reported decreased fetal movements for improving pregnancy outcomes. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD009148.pub2]

Irion 1998

Irion O, Boulavain M. Induction of labour for suspected fetal macrosomia. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD000938]

Kean 1996

Kean LH, Liu DT. Antenatal care as a screening tool for the detection of small for gestational age babies in the low risk population. Journal of Obstetrics and Gynaecology 1996;16(2):77‐82.

Maulik 2004

Maulik D, Sicuranza G, Lysikiewicz A, Figueroa R. Fetal growth restriction: 3 keys to successful management. OBG Management 2004;16(6):48‐64.

Maulik 2006

Maulik D. Management of fetal growth restriction: an evidence‐based approach. Clinical Obstetrics and Gynecology 2006;49(2):320‐34.

Moore 1997

Moore TR. Clinical assessment of amniotic fluid. Clinical Obstetrics and Gynecology 1997;40:303‐13.

Morrison 1995

Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. British Journal of Obstetrics and Gynaecology 1995;102:101‐6.

NICE/RCOG 2007

National Collaborating Centre for Women's and Children's Health. Intrapartum care: Care of Healthy Women and their Babies During Childbirth. NICE Clinical Guideline 55. London: NICE, 2007 September.

Nicholson 2007

Nicholson J, Caughey A, Parry S, Rosen S, Evans A, Macones G. Prospective randomized trial of the active management of risk in pregnancy at term: improved birth outcomes from prostaglandin‐assisted preventive labor induction. American Journal of Obstetrics and Gynecology 2007;197(6 Suppl 1):S37, Abstract no: 84.

Novikova 2011

Novikova N, Cluver C, Koopmans CM. Delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD009273]

Peek 2009

Peek MJ, Nanan RK. The role of sepsis in the AMOR‐IPAT Trial. American Journal of Obstetrics & Gynecology 2009;200(4):e12.

RCOG 2011

Whitworth MK, Fisher M, Heazell A. Reduced Fetal Movements. Greentop Guideline 57. Royal College of Obstetricians and Gynaecologists, February 2011.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Seyb 1999

Seyb ST, Berka RJ, Socol ML, Dooley SL. Risk of cesarean delivery with elective induction of labor at term in nulliparous women. Obstetrics & Gynecology  1999;94(4):600‐7.

Smith 1992

Smith CV, Plambeck RD, Rayburn WF, Albaugh KJ. Relation of mild idiopathic polyhydramnios to perinatal outcome. Obstetrics & Gynecology 1992;79(3):387‐9.

Stock 2012

Stock SJ, Bricker L, Norman JE. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD008968.pub2]

Stutchfield 2005

Stutchfield P, Whitaker R, Russell I. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ 2005;331:662. [DOI: 10.1136/bmj.38547.416493.06]

Tajik 2012

Tajik P, Boers K, van Wyk L, Mol B, Sicco S. Evaluation of markers guiding management decision for intrauterine growth restriction: a sub‐analysis of a randomized trial, DIGITAT. American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S199‐200.

Tajik 2014

Tajik P, van Wyk L, Boers KE, le Cessie S, Zafarmand MH, Roumen F, et al. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2014;172:20‐5.

Van Wyk 2012

Van Wyk L. Effects on (neuro) developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intra‐uterine growth restricted infants: long‐term outcomes of the DIGITAT‐trial. American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S19‐20.

Van Wyk 2012a

Van Wyk L, Boers KE, Van der Post JAM, Van Pampus MG, Van Wassenaer AG, Van Baar AL, et al. DIGITAT Study Group. Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth‐restricted infants: Long‐term outcomes of the DIGITAT trial. American Journal of Obstetrics and Gynecology 2012;206(5):406.e1‐406.e7.

Vijgen 2013

Vijgen SM, Boers KE, Opmeer BC, Bijlenga D, Bekedam DJ, Bloemenkamp KW, et al. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial). European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013;170(2):358‐63.

Visser 2009

Visser GHA, Eilers PHC, Elferink‐Stinkens PM, Merkus HM WM, Wit JM. New Dutch reference curves for birthweight by gestational age. Early Human Development 2009;85(12):737‐44.

Willekes 2011

Willekes C, van der Post J, Mol BW, Roumen F, Boers K, Delemarre F, et al. Neonatal morbidity after induction vs expectant monitoring in at term growth restriction (DIGITAT trial). American Journal of Obstetrics and Gynecology 2011;204(1 Suppl 1):S71.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Boers 2010

Methods

Multicentre randomised equivalence trial.

Participants

Setting: 8 academic and 44 non‐academic hospitals in The Netherlands between November 2004 and November 2008.

Inclusion criteria: pregnant women between 36 + 0 and 41 + 0 weeks’ gestation who had a singleton fetus in cephalic presentation, suspected intrauterine growth restriction and who were under specialised obstetric care. Suspected intrauterine growth restriction was defined as fetal abdominal circumference below the 10th percentile, estimated fetal weight below the 10th percentile, flattening of the growth curve in the third trimester (as judged by a clinician), or the presence of all 3 factors.

Exclusion criteria: exclusion criteria were previous caesarean section, diabetes mellitus or gestational diabetes requiring insulin therapy, renal failure, HIV seropositivity, prelabour rupture of membranes, severe pre‐eclampsia, HELLP syndrome (haemolysis, elevated liver enzymes, and low platelet count), or a fetus with aneuploidy or congenital abnormalities suspected on ultrasound. Fetuses with decreased or absent movements, and those with abnormal heart rate tracings, were also excluded.

Number randomised: 650 women ‐ 321 to induction of labour and 329 to expectant management in overall study, which included women from 36 weeks' gestation. For this review data included term infants ≥ 37 weeks' gestation ‐ total 459 randomised ‐ 227 to induction of labour and 232 to expectant management.

Interventions

Induction of labour group: participants allocated to the induction of labour group were induced within 48 hours of randomisation. If the Bishop score at randomisation was greater than 6, labour was induced with amniotomy and, if necessary, augmented with oxytocin. Otherwise cervical ripening was performed with intracervical or intravaginal prostaglandin or a Foley balloon catheter.

Expectant management: women were monitored until the onset of spontaneous labour with daily fetal movement counts and twice‐weekly heart rate tracings, ultrasound examination, maternal blood pressure measurement, assessment of proteinuria, laboratory tests of liver and kidney function, and full blood count. Induction of labour or planned caesarean section was performed for obstetrical indications.

Outcomes

Primary: initial study: Composite measure of adverse neonatal outcome defined as death before hospital discharge, 5‐minute Apgar score of less than 7, umbilical artery pH of less than 7.05, or admission to neonatal intensive care.

Follow‐up study: 2‐year neurodevelopmental outcomes using ages and stages questionnaire and the child behaviour checklist.

Secondary: caesarean section, instrumental vaginal delivery, length of stay in the neonatal intensive care or neonatal ward, length of stay in the maternal hospital, and maternal morbidity (defined as postpartum haemorrhage of more than 1000 mL, development of gestational hypertension or pre‐eclampsia, eclampsia, pulmonary oedema, thromboembolism, or any other serious adverse event).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Participant data were entered into a secure web‐based database. Women were randomly allocated to either induction or expectant monitoring in a 1:1 ratio using varied sized block randomisation with stratification for centre and parity.

Allocation concealment (selection bias)

Unclear risk

Secure web‐based database ‐ unclear whether centralised telephone allocation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Complete outcome data reported and analysis by intention‐to‐treat.

Selective reporting (reporting bias)

Low risk

All pre‐specified outcomes reported on.

Other bias

Low risk

No apparent risk of other bias.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Participants and personnel not blinded, however, this is likely to be a low risk of bias secondary to the intervention being assessed.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Outcome assessors not blinded ‐ In initial study, primary outcomes not subject to bias, e.g. mortality, weight, gestational age, however in the follow‐up study there is potential for bias in the interpretation of the developmental measures used.

Ek 2005

Methods

Prospective pilot RCT.

Participants

Setting: Department of Obstetrics and Gynaecology, Karolinska University Hospital, Huddinge, Sweden from late 1999 until spring 2001.

Inclusion criteria: patients referred at 41 completed weeks with uncomplicated pregnancies; amniotic fluid index < 50 mm.

Exclusion criteria: estimated fetal size < ‐22%; pathological umbilical artery blood flow; abnormal cardiotocograph.

Number randomised: 54 women, 26 to expectant management and 28 to induction of labour.

Interventions

Induction of labour: induction of labour was performed the same or following day. Patients with unfavourable cervix had a transcervical Foley catheter inserted for a maximum of 7 hours prior to amniotomy and oxytocin infusion, while patients with a favourable cervix primarily had amniotomy and oxytocin infusion.

Expectant management: no monitoring was done prior to spontaneous onset of labour. Those who did not go into labour spontaneously by 42 completed weeks were then managed according to department protocol.

Outcomes

Primary maternal: mode of delivery.

Secondary maternal: day at delivery.

Primary fetal: umbilical cord pH; Apgar score at 1, 5 and 10 minutes.

Secondary fetal: birthweight; number of admissions to the neonatal intensive care unit.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Patients were randomised, by sealed envelopes, after having given informed consent. No mention is made of how the randomisation sequence was generated.

Allocation concealment (selection bias)

Unclear risk

No mention is made as to how concealment was preserved. The information was stored in anonymous protocols at evaluation.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Trial was based on intention to treat. All patients completed the study and there were no treatment withdrawals.

Selective reporting (reporting bias)

Low risk

All pre‐specified outcomes reported on.

Other bias

Low risk

No apparent risk of other bias.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

This information was not provided however this is likely to be a low risk of bias secondary to the intervention being assessed.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

This information was not provided.

van den Hove 2006

Methods

Pilot RCT.

Participants

Setting: Department of Obstetrics and Gynaecology, Atrium Medical Centre, Heerlen, The Netherlands between January 2002 and April 2004.

Inclusion criteria: pregnant women with suspected intrauterine growth restriction after 37 weeks’ gestation, based on clinical examination (measuring fundal height) and/or ultrasound biometry (fetal abdominal circumference (FAC) < 10th percentile or a declining FACcurve), singleton pregnancy; an accurate ultrasound dating scan performed before 20 weeks; a normal cardiotocograph; and doubt by the attending clinician whether to induce or to await spontaneous delivery.

Exclusion criteria: patients with multifetal pregnancies, uncertain gestational age, abnormal fetal presentations, or maternal diseases requiring induction of labour.

Number randomised: 33 consented to take part. 16 were allocated to the labour induction group, and 17 to await the spontaneous onset of labour.

Interventions

Patients were randomly allocated after stratification for parity to either induction of labour within 48 hours (labour induction group) or to await spontaneous onset of labour (expectant management group). Methods of labour induction were prostaglandin gel for cervical ripening and amniotomy and oxytocin intravenously according to local practice and individual preference. Participants allocated to the expectant management group were monitored with weekly measurement of the umbilical artery Doppler waveform and cardiotocography twice weekly. Additional monitoring was done if indicated. Labour was induced in the expectant management group if the clinician considered this necessary on the basis of changes in foetal or maternal condition.

Outcomes

Primary: obstetrical intervention rates and neonatal outcomes.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Patients were randomly allocated by drawing of a sealed opaque envelope. 2 series of envelopes, 1 for nulliparous and another for multiparous women, were filled at random by a statistician with a folded paper ‘‘induction’’ or ‘‘expectation’’ and numbered consecutively. The envelopes were opened in sequence of numbers in presence of the patient. No envelope was missed.

Allocation concealment (selection bias)

Low risk

Sealed opaque envelopes were used.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Analyses were performed by intention‐to‐treat. All patients completed the study and there were no treatment withdrawals.

Selective reporting (reporting bias)

Low risk

The primary outcomes were reported.

Other bias

Low risk

No apparent risk of other bias.

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

This information was not provided however this is likely to be a low risk of bias secondary to the intervention being assessed.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

This information was not provided.

RCT: randomised controlled trial

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Conway 2000

Abstract publication only. Unable to use data without information on numbers randomised to each arm. The author has been contacted but has not yet supplied the requested information.

Dogra 2012

This study randomised women with acquired and congenital heart disease and not suspicion of fetal compromise as defined in this review. Study results not yet published.

Nicholson 2008

Randomised women 32 ‐ 37.5 weeks. Randomised based on pre‐specified risk factors ‐ demographic or medical. Therefore, not randomised on suspicion of fetal compromise as defined in this review.

Pri‐Paz 2008

A prospective randomised controlled trial entitled "Active Management Of Risk In Pregnancy At Term to Reduce Rate of Cesarean Deliveries (AMOR‐IPAT)". It's aim was to determine if active management of risks in pregnancy at term by inducing patients would not decrease the caesarean delivery rate or change neonatal outcomes. No published results were found for this trial, only a link stating the trial had been terminated. Multiple attempts to contact the author for results were unsuccessful.

Data and analyses

Open in table viewer
Comparison 1. Planned early delivery versus expectant management

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Perinatal mortality Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 1.1

Comparison 1 Planned early delivery versus expectant management, Outcome 1 Perinatal mortality.

Comparison 1 Planned early delivery versus expectant management, Outcome 1 Perinatal mortality.

2 Major neonatal morbidity Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.81]

Analysis 1.2

Comparison 1 Planned early delivery versus expectant management, Outcome 2 Major neonatal morbidity.

Comparison 1 Planned early delivery versus expectant management, Outcome 2 Major neonatal morbidity.

3 Neurodevelopmental disability/impairment Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

2.04 [0.62, 6.69]

Analysis 1.3

Comparison 1 Planned early delivery versus expectant management, Outcome 3 Neurodevelopmental disability/impairment.

Comparison 1 Planned early delivery versus expectant management, Outcome 3 Neurodevelopmental disability/impairment.

4 Maternal mortality Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

3.07 [0.13, 74.87]

Analysis 1.4

Comparison 1 Planned early delivery versus expectant management, Outcome 4 Maternal mortality.

Comparison 1 Planned early delivery versus expectant management, Outcome 4 Maternal mortality.

5 Major maternal morbidity Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.38, 2.22]

Analysis 1.5

Comparison 1 Planned early delivery versus expectant management, Outcome 5 Major maternal morbidity.

Comparison 1 Planned early delivery versus expectant management, Outcome 5 Major maternal morbidity.

6 Neonatal seizures Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 1.6

Comparison 1 Planned early delivery versus expectant management, Outcome 6 Neonatal seizures.

Comparison 1 Planned early delivery versus expectant management, Outcome 6 Neonatal seizures.

7 Necrotising enterocolitis Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Analysis 1.7

Comparison 1 Planned early delivery versus expectant management, Outcome 7 Necrotising enterocolitis.

Comparison 1 Planned early delivery versus expectant management, Outcome 7 Necrotising enterocolitis.

8 Respiratory distress syndrome Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 7.98]

Analysis 1.8

Comparison 1 Planned early delivery versus expectant management, Outcome 8 Respiratory distress syndrome.

Comparison 1 Planned early delivery versus expectant management, Outcome 8 Respiratory distress syndrome.

9 Meconium aspiration Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.01, 8.32]

Analysis 1.9

Comparison 1 Planned early delivery versus expectant management, Outcome 9 Meconium aspiration.

Comparison 1 Planned early delivery versus expectant management, Outcome 9 Meconium aspiration.

10 Gestational age at birth (days) Show forest plot

1

459

Mean Difference (IV, Fixed, 95% CI)

‐9.5 [‐10.82, ‐8.18]

Analysis 1.10

Comparison 1 Planned early delivery versus expectant management, Outcome 10 Gestational age at birth (days).

Comparison 1 Planned early delivery versus expectant management, Outcome 10 Gestational age at birth (days).

11 Gestational age ≥ 40 weeks (not pre‐specified) Show forest plot

1

33

Risk Ratio (M‐H, Fixed, 95% CI)

0.10 [0.01, 0.67]

Analysis 1.11

Comparison 1 Planned early delivery versus expectant management, Outcome 11 Gestational age ≥ 40 weeks (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 11 Gestational age ≥ 40 weeks (not pre‐specified).

12 Apgar score < 7 at 5 minutes Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

2.56 [0.50, 13.04]

Analysis 1.12

Comparison 1 Planned early delivery versus expectant management, Outcome 12 Apgar score < 7 at 5 minutes.

Comparison 1 Planned early delivery versus expectant management, Outcome 12 Apgar score < 7 at 5 minutes.

13 Resuscitation required Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.11 [0.01, 2.10]

Analysis 1.13

Comparison 1 Planned early delivery versus expectant management, Outcome 13 Resuscitation required.

Comparison 1 Planned early delivery versus expectant management, Outcome 13 Resuscitation required.

14 Requirement for mechanical ventilation Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.20 [0.01, 4.11]

Analysis 1.14

Comparison 1 Planned early delivery versus expectant management, Outcome 14 Requirement for mechanical ventilation.

Comparison 1 Planned early delivery versus expectant management, Outcome 14 Requirement for mechanical ventilation.

15 Birthweight < 10 centile Show forest plot

2

491

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.88, 1.10]

Analysis 1.15

Comparison 1 Planned early delivery versus expectant management, Outcome 15 Birthweight < 10 centile.

Comparison 1 Planned early delivery versus expectant management, Outcome 15 Birthweight < 10 centile.

16 Birthweight < 2.3 centile (not pre‐specified) Show forest plot

2

491

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.36, 0.73]

Analysis 1.16

Comparison 1 Planned early delivery versus expectant management, Outcome 16 Birthweight < 2.3 centile (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 16 Birthweight < 2.3 centile (not pre‐specified).

17 Admission to NICU Show forest plot

3

545

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.35, 2.23]

Analysis 1.17

Comparison 1 Planned early delivery versus expectant management, Outcome 17 Admission to NICU.

Comparison 1 Planned early delivery versus expectant management, Outcome 17 Admission to NICU.

18 Admission to intermediate care nursery (not pre‐specified) Show forest plot

2

491

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [1.02, 1.61]

Analysis 1.18

Comparison 1 Planned early delivery versus expectant management, Outcome 18 Admission to intermediate care nursery (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 18 Admission to intermediate care nursery (not pre‐specified).

19 Length of stay in NICU/SCN (days) Show forest plot

1

459

Mean Difference (IV, Fixed, 95% CI)

0.0 [‐1.28, 1.28]

Analysis 1.19

Comparison 1 Planned early delivery versus expectant management, Outcome 19 Length of stay in NICU/SCN (days).

Comparison 1 Planned early delivery versus expectant management, Outcome 19 Length of stay in NICU/SCN (days).

20 Interval (days) between randomisation and delivery Show forest plot

1

459

Mean Difference (IV, Fixed, 95% CI)

‐8.68 [‐10.04, ‐7.32]

Analysis 1.20

Comparison 1 Planned early delivery versus expectant management, Outcome 20 Interval (days) between randomisation and delivery.

Comparison 1 Planned early delivery versus expectant management, Outcome 20 Interval (days) between randomisation and delivery.

21 Neonatal sepsis Show forest plot

2

366

Risk Ratio (M‐H, Fixed, 95% CI)

3.18 [0.14, 72.75]

Analysis 1.21

Comparison 1 Planned early delivery versus expectant management, Outcome 21 Neonatal sepsis.

Comparison 1 Planned early delivery versus expectant management, Outcome 21 Neonatal sepsis.

22 Caesarean section Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.65, 1.59]

Analysis 1.22

Comparison 1 Planned early delivery versus expectant management, Outcome 22 Caesarean section.

Comparison 1 Planned early delivery versus expectant management, Outcome 22 Caesarean section.

23 Placental abruption Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

3.07 [0.13, 74.87]

Analysis 1.23

Comparison 1 Planned early delivery versus expectant management, Outcome 23 Placental abruption.

Comparison 1 Planned early delivery versus expectant management, Outcome 23 Placental abruption.

24 Pre‐eclampsia Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.63 [0.27, 1.49]

Analysis 1.24

Comparison 1 Planned early delivery versus expectant management, Outcome 24 Pre‐eclampsia.

Comparison 1 Planned early delivery versus expectant management, Outcome 24 Pre‐eclampsia.

25 Induction of labour Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

2.05 [1.78, 2.37]

Analysis 1.25

Comparison 1 Planned early delivery versus expectant management, Outcome 25 Induction of labour.

Comparison 1 Planned early delivery versus expectant management, Outcome 25 Induction of labour.

26 Vaginal birth Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.90, 1.07]

Analysis 1.26

Comparison 1 Planned early delivery versus expectant management, Outcome 26 Vaginal birth.

Comparison 1 Planned early delivery versus expectant management, Outcome 26 Vaginal birth.

27 Assisted vaginal birth Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

1.19 [0.69, 2.04]

Analysis 1.27

Comparison 1 Planned early delivery versus expectant management, Outcome 27 Assisted vaginal birth.

Comparison 1 Planned early delivery versus expectant management, Outcome 27 Assisted vaginal birth.

28 Breastfeeding Show forest plot

1

218

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.85, 1.40]

Analysis 1.28

Comparison 1 Planned early delivery versus expectant management, Outcome 28 Breastfeeding.

Comparison 1 Planned early delivery versus expectant management, Outcome 28 Breastfeeding.

29 Breastfeeding (weeks) Show forest plot

1

124

Mean Difference (IV, Fixed, 95% CI)

1.74 [‐3.37, 6.85]

Analysis 1.29

Comparison 1 Planned early delivery versus expectant management, Outcome 29 Breastfeeding (weeks).

Comparison 1 Planned early delivery versus expectant management, Outcome 29 Breastfeeding (weeks).

30 Maternal hospital stay (days) (not pre‐specified) Show forest plot

1

33

Mean Difference (IV, Fixed, 95% CI)

1.0 [0.68, 1.32]

Analysis 1.30

Comparison 1 Planned early delivery versus expectant management, Outcome 30 Maternal hospital stay (days) (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 30 Maternal hospital stay (days) (not pre‐specified).

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Planned early delivery versus expectant management, Outcome 1 Perinatal mortality.
Figuras y tablas -
Analysis 1.1

Comparison 1 Planned early delivery versus expectant management, Outcome 1 Perinatal mortality.

Comparison 1 Planned early delivery versus expectant management, Outcome 2 Major neonatal morbidity.
Figuras y tablas -
Analysis 1.2

Comparison 1 Planned early delivery versus expectant management, Outcome 2 Major neonatal morbidity.

Comparison 1 Planned early delivery versus expectant management, Outcome 3 Neurodevelopmental disability/impairment.
Figuras y tablas -
Analysis 1.3

Comparison 1 Planned early delivery versus expectant management, Outcome 3 Neurodevelopmental disability/impairment.

Comparison 1 Planned early delivery versus expectant management, Outcome 4 Maternal mortality.
Figuras y tablas -
Analysis 1.4

Comparison 1 Planned early delivery versus expectant management, Outcome 4 Maternal mortality.

Comparison 1 Planned early delivery versus expectant management, Outcome 5 Major maternal morbidity.
Figuras y tablas -
Analysis 1.5

Comparison 1 Planned early delivery versus expectant management, Outcome 5 Major maternal morbidity.

Comparison 1 Planned early delivery versus expectant management, Outcome 6 Neonatal seizures.
Figuras y tablas -
Analysis 1.6

Comparison 1 Planned early delivery versus expectant management, Outcome 6 Neonatal seizures.

Comparison 1 Planned early delivery versus expectant management, Outcome 7 Necrotising enterocolitis.
Figuras y tablas -
Analysis 1.7

Comparison 1 Planned early delivery versus expectant management, Outcome 7 Necrotising enterocolitis.

Comparison 1 Planned early delivery versus expectant management, Outcome 8 Respiratory distress syndrome.
Figuras y tablas -
Analysis 1.8

Comparison 1 Planned early delivery versus expectant management, Outcome 8 Respiratory distress syndrome.

Comparison 1 Planned early delivery versus expectant management, Outcome 9 Meconium aspiration.
Figuras y tablas -
Analysis 1.9

Comparison 1 Planned early delivery versus expectant management, Outcome 9 Meconium aspiration.

Comparison 1 Planned early delivery versus expectant management, Outcome 10 Gestational age at birth (days).
Figuras y tablas -
Analysis 1.10

Comparison 1 Planned early delivery versus expectant management, Outcome 10 Gestational age at birth (days).

Comparison 1 Planned early delivery versus expectant management, Outcome 11 Gestational age ≥ 40 weeks (not pre‐specified).
Figuras y tablas -
Analysis 1.11

Comparison 1 Planned early delivery versus expectant management, Outcome 11 Gestational age ≥ 40 weeks (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 12 Apgar score < 7 at 5 minutes.
Figuras y tablas -
Analysis 1.12

Comparison 1 Planned early delivery versus expectant management, Outcome 12 Apgar score < 7 at 5 minutes.

Comparison 1 Planned early delivery versus expectant management, Outcome 13 Resuscitation required.
Figuras y tablas -
Analysis 1.13

Comparison 1 Planned early delivery versus expectant management, Outcome 13 Resuscitation required.

Comparison 1 Planned early delivery versus expectant management, Outcome 14 Requirement for mechanical ventilation.
Figuras y tablas -
Analysis 1.14

Comparison 1 Planned early delivery versus expectant management, Outcome 14 Requirement for mechanical ventilation.

Comparison 1 Planned early delivery versus expectant management, Outcome 15 Birthweight < 10 centile.
Figuras y tablas -
Analysis 1.15

Comparison 1 Planned early delivery versus expectant management, Outcome 15 Birthweight < 10 centile.

Comparison 1 Planned early delivery versus expectant management, Outcome 16 Birthweight < 2.3 centile (not pre‐specified).
Figuras y tablas -
Analysis 1.16

Comparison 1 Planned early delivery versus expectant management, Outcome 16 Birthweight < 2.3 centile (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 17 Admission to NICU.
Figuras y tablas -
Analysis 1.17

Comparison 1 Planned early delivery versus expectant management, Outcome 17 Admission to NICU.

Comparison 1 Planned early delivery versus expectant management, Outcome 18 Admission to intermediate care nursery (not pre‐specified).
Figuras y tablas -
Analysis 1.18

Comparison 1 Planned early delivery versus expectant management, Outcome 18 Admission to intermediate care nursery (not pre‐specified).

Comparison 1 Planned early delivery versus expectant management, Outcome 19 Length of stay in NICU/SCN (days).
Figuras y tablas -
Analysis 1.19

Comparison 1 Planned early delivery versus expectant management, Outcome 19 Length of stay in NICU/SCN (days).

Comparison 1 Planned early delivery versus expectant management, Outcome 20 Interval (days) between randomisation and delivery.
Figuras y tablas -
Analysis 1.20

Comparison 1 Planned early delivery versus expectant management, Outcome 20 Interval (days) between randomisation and delivery.

Comparison 1 Planned early delivery versus expectant management, Outcome 21 Neonatal sepsis.
Figuras y tablas -
Analysis 1.21

Comparison 1 Planned early delivery versus expectant management, Outcome 21 Neonatal sepsis.

Comparison 1 Planned early delivery versus expectant management, Outcome 22 Caesarean section.
Figuras y tablas -
Analysis 1.22

Comparison 1 Planned early delivery versus expectant management, Outcome 22 Caesarean section.

Comparison 1 Planned early delivery versus expectant management, Outcome 23 Placental abruption.
Figuras y tablas -
Analysis 1.23

Comparison 1 Planned early delivery versus expectant management, Outcome 23 Placental abruption.

Comparison 1 Planned early delivery versus expectant management, Outcome 24 Pre‐eclampsia.
Figuras y tablas -
Analysis 1.24

Comparison 1 Planned early delivery versus expectant management, Outcome 24 Pre‐eclampsia.

Comparison 1 Planned early delivery versus expectant management, Outcome 25 Induction of labour.
Figuras y tablas -
Analysis 1.25

Comparison 1 Planned early delivery versus expectant management, Outcome 25 Induction of labour.

Comparison 1 Planned early delivery versus expectant management, Outcome 26 Vaginal birth.
Figuras y tablas -
Analysis 1.26

Comparison 1 Planned early delivery versus expectant management, Outcome 26 Vaginal birth.

Comparison 1 Planned early delivery versus expectant management, Outcome 27 Assisted vaginal birth.
Figuras y tablas -
Analysis 1.27

Comparison 1 Planned early delivery versus expectant management, Outcome 27 Assisted vaginal birth.

Comparison 1 Planned early delivery versus expectant management, Outcome 28 Breastfeeding.
Figuras y tablas -
Analysis 1.28

Comparison 1 Planned early delivery versus expectant management, Outcome 28 Breastfeeding.

Comparison 1 Planned early delivery versus expectant management, Outcome 29 Breastfeeding (weeks).
Figuras y tablas -
Analysis 1.29

Comparison 1 Planned early delivery versus expectant management, Outcome 29 Breastfeeding (weeks).

Comparison 1 Planned early delivery versus expectant management, Outcome 30 Maternal hospital stay (days) (not pre‐specified).
Figuras y tablas -
Analysis 1.30

Comparison 1 Planned early delivery versus expectant management, Outcome 30 Maternal hospital stay (days) (not pre‐specified).

Summary of findings for the main comparison. Planned early delivery compared with expectant management for improving outcomes of the term suspected compromised baby

Planned early delivery compared with expectant management for improving outcomes of the term suspected compromised baby

Patient or population: pregnant women with a term suspected compromised baby
Settings: studies took place in The Netherlands and Sweden
Intervention: planned early delivery
Comparison: expectant management

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Expectant management

Planned early delivery

Perinatal mortality
(stillbirth ‐ death of fetus prior to birth; neonatal death ‐ death within the first 28 days of birth; or infant death ‐ death after the first 28 days)

See comment

See comment

Not estimable

459
(1 study)

⊕⊕⊕⊝
moderate1

Major neonatal morbidity
one or more of the following: hypoxic ischaemic encephalopathy (HIE) ‐ grade II or III, necrotising enterocolitis (NEC), need for ongoing ventilation, meconium aspiration syndrome, seizures, need for therapeutic hypothermia
Follow‐up: 0‐22 days

Study population

RR 0.15
(0.01 to 2.81)

459
(1 study)

⊕⊕⊝⊝
low2,3

13 per 1000

2 per 1000
(0 to 36)

Neurodevelopmental disability/impairment
CBCL, Ages and Stages Questionnaire
Follow‐up: mean 2 years

Study population

RR 2.04
(0.62 to 6.69)

459
(1 study)

⊕⊕⊝⊝
low2,3

17 per 1000

35 per 1000
(11 to 115)

Maternal mortality
Follow‐up: 0‐10 days

Study population

RR 3.07
(0.13 to 74.87)

459
(1 study)

⊕⊕⊝⊝
low2,3

0 per 1000

0 per 1000
(0 to 0)

Significant maternal morbidity
one or more of the following: significant postpartum haemorrhage requiring blood transfusion; maternal admission to intensive care unit; uterine rupture; hysterectomy

Study population

RR 0.92
(0.38 to 2.22)

459
(1 study)

⊕⊕⊝⊝
low2,3

43 per 1000

40 per 1000
(16 to 96)

Admission to NICU

Study population

RR 0.88
(0.35 to 2.23)

545
(3 studies)

⊕⊝⊝⊝
very low2,3,4

33 per 1000

29 per 1000
(11 to 73)

Moderate

26 per 1000

23 per 1000
(9 to 58)

Caesarean section

Study population

RR 1.02
(0.65 to 1.59)

546
(3 studies)

⊕⊕⊝⊝
low5,6

124 per 1000

126 per 1000
(80 to 197)

Moderate

154 per 1000

157 per 1000
(100 to 245)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 There were no events for this outcome.
2 Few total events (< 30).
3 Wide CI crossing line of no effect and RR > 25%.
4 Although all studies address outcome of NICU admission, 2 studies included additional outcome of intermediate nursery admission. Overall this may have compromised the total number of events comparatively.
5 One study did not give outcomes for elective C/S, only emergency C/S assessed.
6 Two out of three studies had wide CIs crossing the line of no effect.

CBCL: child behaviour checklist
NICU: neonatal intensive care unit

Figuras y tablas -
Summary of findings for the main comparison. Planned early delivery compared with expectant management for improving outcomes of the term suspected compromised baby
Comparison 1. Planned early delivery versus expectant management

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Perinatal mortality Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Major neonatal morbidity Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.81]

3 Neurodevelopmental disability/impairment Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

2.04 [0.62, 6.69]

4 Maternal mortality Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

3.07 [0.13, 74.87]

5 Major maternal morbidity Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.38, 2.22]

6 Neonatal seizures Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7 Necrotising enterocolitis Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Respiratory distress syndrome Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 7.98]

9 Meconium aspiration Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.01, 8.32]

10 Gestational age at birth (days) Show forest plot

1

459

Mean Difference (IV, Fixed, 95% CI)

‐9.5 [‐10.82, ‐8.18]

11 Gestational age ≥ 40 weeks (not pre‐specified) Show forest plot

1

33

Risk Ratio (M‐H, Fixed, 95% CI)

0.10 [0.01, 0.67]

12 Apgar score < 7 at 5 minutes Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

2.56 [0.50, 13.04]

13 Resuscitation required Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.11 [0.01, 2.10]

14 Requirement for mechanical ventilation Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.20 [0.01, 4.11]

15 Birthweight < 10 centile Show forest plot

2

491

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.88, 1.10]

16 Birthweight < 2.3 centile (not pre‐specified) Show forest plot

2

491

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.36, 0.73]

17 Admission to NICU Show forest plot

3

545

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.35, 2.23]

18 Admission to intermediate care nursery (not pre‐specified) Show forest plot

2

491

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [1.02, 1.61]

19 Length of stay in NICU/SCN (days) Show forest plot

1

459

Mean Difference (IV, Fixed, 95% CI)

0.0 [‐1.28, 1.28]

20 Interval (days) between randomisation and delivery Show forest plot

1

459

Mean Difference (IV, Fixed, 95% CI)

‐8.68 [‐10.04, ‐7.32]

21 Neonatal sepsis Show forest plot

2

366

Risk Ratio (M‐H, Fixed, 95% CI)

3.18 [0.14, 72.75]

22 Caesarean section Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.65, 1.59]

23 Placental abruption Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

3.07 [0.13, 74.87]

24 Pre‐eclampsia Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

0.63 [0.27, 1.49]

25 Induction of labour Show forest plot

1

459

Risk Ratio (M‐H, Fixed, 95% CI)

2.05 [1.78, 2.37]

26 Vaginal birth Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.90, 1.07]

27 Assisted vaginal birth Show forest plot

3

546

Risk Ratio (M‐H, Fixed, 95% CI)

1.19 [0.69, 2.04]

28 Breastfeeding Show forest plot

1

218

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.85, 1.40]

29 Breastfeeding (weeks) Show forest plot

1

124

Mean Difference (IV, Fixed, 95% CI)

1.74 [‐3.37, 6.85]

30 Maternal hospital stay (days) (not pre‐specified) Show forest plot

1

33

Mean Difference (IV, Fixed, 95% CI)

1.0 [0.68, 1.32]

Figuras y tablas -
Comparison 1. Planned early delivery versus expectant management